The company added that the cost savings would mitigate the impact of a potential reduction in revenue and related operating ...

Illumina on Monday lowered its annual forecast and said it plans to cut $100 million in spending after China announced a ban on imports of its genetic sequencing instruments.

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies ... Gene sequencers help determine the sequence of DNA or RNA, allowing scientists to study genetic ...

Spatial transcriptomics is a cutting-edge technique that characterizes gene expression within sections of tissue, such as ...

The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.

Amid increasing economic tensions with the United States, China recently announced that it would ban Illumina, a U.S.-based company and the ...

Beijing banned imports of Illumina’s gene-sequencing machines in response to U.S. tariffs.

Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue ...

Mammalian genomes are organized by multi-level folding, yet how this organization contributes to cell type-specific transcription remain unclear. We uncovered that the nuclear protein SATB1 ...

BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...